Actions for stakeholders to develop better real-world evidence for HTA bodies/payers decision making

20252 citationsJournal Articlehybrid Open Access

Authors

Ashley Jaksa · Aetion (United States)

Alina N Pavel · Flint Institute Of Arts

Matti Aapro · Clinique de Genolier

Niklas Hedberg · Swedish Dental Association

Victoria Hodgkinson · Luminex (United States)

Laurie Lambert · Canadian Agency for Drugs and Technologies in Health

François Meyer

Abstract

Carrying out these actions will facilitate the development of methodological best practices for generating RWE to inform HTA of highly innovative medicines and build trust between stakeholders in the use of RWE.

Topics & Keywords

Health Systems, Economic Evaluations, Quality of Life

UN Sustainable Development Goals

Peace, Justice and strong institutions

Publication Details

Published in: International Journal of Technology Assessment in Health Care

Volume 41, Issue 1, pp. e52-e52

DOI: 10.1017/s0266462325100238

Field-Weighted Citation Impact: 6.53